Loading...
Cart
0

Sangers Sequencing Service Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others) and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) - Global Opportunity Analysis and Industry Forecast, 2013-2025

Get 20% Free Customization In This Report
LI_184611
Pages: 150
Apr 2018 | 1872 Views
 
Author(s) : Sohail Shaikh & Pallavi Jaiswal
Tables: 39
Charts: 37
 
 

Sanger’s Sequencing Service Market Overview:

The Global Sanger’s Sequencing Service Market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025. Sanger’s sequencing is one of the most pivotal techniques used by molecular biologists worldwide for sequence analysis. In this method, the target nucleic acid is reproduced several times, thereby making fragments of varying lengths.

Technological advancements in sequencing procedures, advantages associated with Sanger’s sequencing, and increase in genome mapping programs boost the growth of the global Sanger’s sequencing services market. Furthermore, rise in investment in R&D and increase in sequencing applications have supplemented the market growth.

However, lack of skilled professionals and standardization concerns associated with sequencing procedures hamper the growth of the industry. On the contrary, untapped potential of emerging markets and the use of cloud computing as a potential data management service are expected to provide lucrative opportunities for the market expansion.

The Sanger’s sequencing service market is segmented based on application, end user, and region. On the basis of application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and others. By end user, it is categorized into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, it is analyzed across the U.S., Europe, Japan, China, India, South-East Asia, and rest of the world (ROW).

       Get more information on this report : Request Sample Pages

The Sanger’s sequencing market share is dominated by the biomarkers & cancer segment, owing to their wide application in oncology research, biomarker discovery, and surge in prevalence of chronic diseases such as cancer.

Get more information on this report : Request Sample Pages

Rise in focus of vendors on emerging markets, such as China, India, and Southeast Asia is expected to boost the market growth. China is projected to witness significant growth in the near future, owing to increase in R&D investment and surge in applications of Sanger’s sequencing. Furthermore, the Chinese region presents noteworthy opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated.

The report provides extensive competitive analysis and profiles of the key market players such as Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt. Limited, and Microsynth AG. Inc. The other players in the value chain (not included in the report) include Laragen, Inc. and StarSEQ GmbH.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends from 2013 to 2025 to identify the prevailing opportunities along with strategic assessment of global Sanger’s sequencing service market.
  • Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry.
  • In-depth analysis based on region assists to understand the regional market and the strategic business planning.
  • The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market.

Sanger's Sequencing Service Market Key Segments:

By Application

  • Diagnostics
  • Biomarkers & Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Others

By End User

  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics

By Region

  • U.S.
  • Europe
  • Japan
  • China
  • India
  • Southeast Asia
  • Rest of the World (ROW)
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market scope and definition
3.2. Competitive environment analysis

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Technological advancements in Sanger's sequencing
3.5.1.2. Surge in applications of Sanger's sequencing
3.5.1.3. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics

3.5.3. Opportunities

3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets

CHAPTER 4: GLOBAL AND REGIONAL Sanger's SEQUENCING SERVICE MARKET SHARE ANALYSIS

4.1. Global Sanger's sequencing services market share analysis, 2017
4.2. U.S. Sanger's sequencing services market share analysis, 2017
4.3. Europe Sanger's sequencing services market share analysis, 2017
4.4. Japan Sanger's sequencing services market share analysis, 2017
4.5. China Sanger's sequencing services market share analysis, 2017
4.6. India Sanger's sequencing services market share analysis, 2017
4.7. South-East Asia Sanger's sequencing services market share analysis, 2017
4.8. Rest of the world Sanger's sequencing services market share analysis, 2017

CHAPTER 5: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Diagnostics

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Biomarkers & cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Reproductive health

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Personalized medicine

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Forensics

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Others

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

CHAPTER 6: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic & government research institutes

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region

6.3. Pharmaceutical companies

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region

6.4. Biotechnology companies

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region

6.5. Hospitals & clinics

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region

CHAPTER 7: GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. U.S.

7.2.1. Key market trends
7.2.2. U.S. market size and forecast

7.2.2.1. U.S. Sanger's sequencing service market, by application
7.2.2.2. U.S. Sanger's sequencing service market, by end user

7.3. Europe

7.3.1. Key market trends
7.3.2. Europe market size and forecast

7.3.2.1. Europe Sanger's sequencing service market, by application
7.3.2.2. Europe Sanger's sequencing service market, by end user

7.4. Japan

7.4.1. Key market trends
7.4.2. Japan market size and forecast

7.4.2.1. Japan Sanger's sequencing service market, by application
7.4.2.2. Japan Sanger's sequencing service market, by end user

7.5. China

7.5.1. Key market trends
7.5.2. China market size and forecast

7.5.2.1. China Sanger's sequencing service market, by application
7.5.2.2. China Sanger's sequencing service market, by end user

7.6. India

7.6.1. Key market trends
7.6.2. India market size and forecast

7.6.2.1. India Sanger's sequencing service market, by application
7.6.2.2. India Sanger's sequencing service market, by end user

7.7. Southeast Asia

7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast

7.7.2.1. Southeast Asia Sanger's sequencing service market, by application
7.7.2.2. Southeast Asia Sanger's sequencing service market, by end user

7.8. Rest of the world

7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast

7.8.2.1. Rest of the world Sanger's sequencing service market, by application
7.8.2.2. Rest of the world Sanger's sequencing service market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. CeMIA SA

8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)

8.2. Fasteris SA

8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)

8.3. GENEWIZ, Inc.

8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments

8.4. GenHunter Corporation

8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)

8.5. Genscript Biotech Corporation

8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)

8.6. LGC Science Group Holdings Limited

8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments

8.7. Microsynth AG

8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)

8.8. Nucleics Pty. Ltd.

8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)

8.9. Quintara Biosciences

8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments

8.10. SciGenom Labs Pvt. Ltd.

8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)

8.11. Source BioScience Plc

8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)

8.12. Thermo Fisher Scientific Inc.

8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments

LIST OF TABLES

TABLE 01. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 02. Sanger's SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013-2025 ($MILLION)
TABLE 03. Sanger's SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, BY REGION, 2013-2025 ($MILLION)
TABLE 04. Sanger's SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013-2025 ($MILLION)
TABLE 05. Sanger's SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013-2025 ($MILLION)
TABLE 06. Sanger's SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013-2025 ($MILLION)
TABLE 07. Sanger's SEQUENCING SERVICE MARKET FOR OTHERS, BY REGION, 2013-2025 ($MILLION)
TABLE 08. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 09. Sanger's SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2025 ($MILLION)
TABLE 10. Sanger's SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 11. Sanger's SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 12. Sanger's SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013-2025 ($MILLION)
TABLE 13. Sanger's SEQUENCING SERVICE MARKET, BY REGION, 2013-2025 ($MILLION)
TABLE 14. U.S. Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 15. U.S. Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 16. Europe Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 17. Europe Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 18. JAPAN Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 19. JAPAN Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 20. CHINA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 21. CHINA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 22. INDIA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 23. INDIA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 24. SOUTHEAST ASIA Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 25. SOUTHEAST ASIA Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 26. REST OF THE WORLD Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 27. REST OF THE WORLD Sanger's SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 28. CEMIA: COMPANY SNAPSHOT
TABLE 29. FASTERIS: COMPANY SNAPSHOT
TABLE 30. GENEWIZ: COMPANY SNAPSHOT
TABLE 31. GENHUNTER: COMPANY SNAPSHOT
TABLE 32. GENSCRIPT: COMPANY SNAPSHOT
TABLE 33. LGC: COMPANY SNAPSHOT
TABLE 34. MICROSYNTH: COMPANY SNAPSHOT
TABLE 35. NUCLEICS: COMPANY SNAPSHOT
TABLE 36. QUINTARA: COMPANY SNAPSHOT
TABLE 37. SCIGENOM LABS: COMPANY SNAPSHOT
TABLE 38. SOURCE BIOSCIENCE: COMPANY SNAPSHOT
TABLE 39. THERMO FISHER: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLOBAL Sanger's SEQUENCING SERVICE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. PATENT ANALYSIS, BY YEAR
FIGURE 08. PATENT ANALYSIS, BY REGION
FIGURE 09. GLOBAL Sanger's SEQUENCING SERVICE MARKET: IMPACT ANALYSES
FIGURE 10. GLOBAL Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 11. U.S. Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 12. Europe Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 13. JAPAN Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA Sanger's SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2017
FIGURE 15. INDIA Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 16. SOUTH-EAST ASIA Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 17. REST OF THE WORLD Sanger's SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 18. GLOBAL Sanger's SEQUENCING SERVICE MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, 2013 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, 2013 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)
FIGURE 24. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR OTHERS, 2013 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE REGION ANALYSIS OF Sanger's SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)
FIGURE 29. GENSCRIPT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 31. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 32. LGC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. SOURCE BIOSCIENCE: NET SALES, 2013-2015 ($MILLION)
FIGURE 34. SOURCE BIOSCIENCE : REVENUE SHARE BY DIVISION, 2015 ($MILLION)
FIGURE 35. THERMO FISHER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)

 
 

Sanger's sequencing has enhanced diverse fields of life sciences through research innovation and development. Biomarker discovery, oncology studies, drug development, personalized genomics, and reproductive health are some of the widely known applications of this technique. Similarly, it has contributed significantly in agricultural & animal and forensic research. Sanger's sequencing services are anticipated to witness high adoption with increase in distinct applications and interventions, such as biomarker discovery, personalized medicine, and others. The market has gained momentum in the R&D sector, owing to increase in genome mapping projects globally. In addition, rise in awareness about Sanger's sequencing and its advantages drives the market.

The demand for Sanger's sequencing services has surged significantly due to reduced cost of sequencing and increase in total number of produced sequence reads per run. However, standardization concerns in diagnostics based on sequencing restrict the market growth. At present, academic & government research institutes are the largest end users of Sanger's sequencing services, followed by pharmaceutical companies, biotechnology companies, and hospitals & clinics. The biotechnology end-user segment is expected to exhibit the highest growth rate throughout the forecast period. However, the utilization of Sanger's sequencing is higher in academic & government research institutes as compared to other end users, as Sanger's sequencing services are routinely employed in hospitals for genomics research, biomarkers detection, and other purposes. The employment of technologically advanced Sanger's sequencing services is highest in the United States, owing to increase in adoption of services and technologies, followed by EU and Japan.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Download Sample

Request Customization

Download Sample

OR

Purchase Full Report of
Sangers Sequencing Service Market- Global Opportunity Analysis and Industry Forecast, 2013-2025

  • Online Only
  • $3456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3840
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5370
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
report-img

Published in  Jan 2015

Erythropoietin Drugs Market

Download Sample
report-img

Published in  Nov 2017

Protein Therapeutics Market

Download Sample
report-img

Published in  Mar 2018

Surgical Equipment Market

Download Sample
report-img

Published in  Aug 2016

Medical Implants Market

Download Sample
 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Buy Full Version
"Sangers Sequencing Service Market"
Purchase Enquiry